2021-01-11,"Are Insiders Buying BioSig Technologies, Inc. (NASDAQ:BSGM) Stock?"
2021-01-06,BioSig CEO Kenneth L. Londoner to Present at the Sidoti Winter 2021 Investor Conference
2020-12-18,BioSigs Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota
2020-12-16,BioSig Technologies Achieves First Commercial Sale Of Its PURE EP System
2020-12-11,BioSig Announces First Sale Of Cardiac Signal Processing Systems
2020-12-11,BioSig Achieves First Commercial Sale of Three PURE EP Systems
2020-12-10,BioSig CEO Kenneth L. Londoner to Present at the 13th Annual LD Micro Main Event Conference
2020-12-03,BioSig to Highlight PURE EP System at the Benzinga Global Small Cap Conference
2020-12-02,Insider Buys BioSig Technologies Stock
2020-11-30,BioSigs PURE EP System to Support Live Patient Cases during EPLive 2020
2020-11-19,Insider Buys BioSig Technologies Shares
2020-11-12,"BioSig to Host Business Update Conference Call on November 18, 2020"
2020-11-12,Is BioSig Technologies (NASDAQ:BSGM) In A Good Position To Invest In Growth?
2020-10-29,BioSig Announces Completion of PURE EP System Installation at New Medical Center
2020-10-28,BioSig Issues October 2020 Shareholder Update Letter
2020-10-26,Biosig stock plunges to lead Nasdaq losers after trial of COVID-19 treatment halted
2020-10-26,ViralClear halts its Phase 2 Hospitalized COVID-19 Trial
2020-09-30,SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST COVID-19
2020-09-22,"ViralClear Expands Ongoing Phase 2 Trial Size for its Oral Anti-Viral for the Treatment of COVID-19, Expands Trial Locations and Appoints Contract Manufacturing Organization to Manufacture Phase 3 Supplies of Merimepodib Oral Solution"
2020-09-21,"Reminder: ViralClear to Host Conference Call and Webcast on September 22, 2020 to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19"
2020-09-15,BioSig Releases PURE EP Study Abstract with Data Presented at European Society of Cardiologys ESC Congress 2020
2020-09-14,BioSig Announces Abstract Acceptance to Computing in Cardiology 2020
2020-09-14,"Reminder: BioSig to Host Conference Call and Webcast on September 15, 2020 to Discuss Unblinding of PURE EP Human Data"
2020-09-09,"ViralClear to Host Conference Call on September 22, 2020, to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19"
2020-09-02,"BioSig to Host Conference Call on September 15, 2020 to Discuss Unblinding of PURE EP Human Data"
2020-08-31,LD Micro 360 Companies Set to Present this Week
2020-08-25,BioSig Technologies to Present at The LD 500 Virtual Conference
2020-08-25,BioSig Technologies to Present at The LD 500 Virtual Conference
2020-08-17,"Could The BioSig Technologies, Inc. (NASDAQ:BSGM) Ownership Structure Tell Us Something Useful?"
2020-08-06,Infectious Diseases Expert Prof. Angus Dalgleish Joins ViralClears Scientific Advisory Board
2020-08-05,ViralClear Appoints Dr. Michael Sofia to Its Scientific Advisory Board
2020-08-05,LD Micro - Announces Preliminary List of Presenters for the LD-500.
2020-08-04,BioSig Installs PURE EP(tm) System at Massachusetts General Hospital
2020-08-03,BioSig Awarded CAGE Code by the Systems for Award Management (SAM)
2020-07-30,"BioSig Technologies to Present at the Proactive Investors One2One Virtual Event on August 4, 2020"
2020-07-23,BioSig Technologies to Participate in LD Micros Zooming with LD
2020-07-20,ViralClear Announces Formation of Its Scientific Advisory Board
2020-07-17,BioSig Technologies to Participate in the B Riley FBR Virtual Infectious Disease Summit
2020-07-16,"BioSig Technologies, Inc. Adopts Stockholder Rights Agreement"
2020-07-16,'Zooming with LD' to Feature 10 Distinct Companies July 20th-31st
2020-07-16,"BioSig Technologies, Inc. Adopts Stockholder Rights Agreement"
2020-07-13,Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites
2020-07-10,BioSig Submits Application to Systems for Award Management (SAM) with U.S. Government
2020-07-01,BioSig Technologies Inc. Appoints Tony Zook to the Board of Directors
2020-06-29,"BioSig Technologies, Inc Closes $17.5 Million Common Stock Offering"
2020-06-24,"BioSig Technologies, Inc. Announces $17.5 Million Common Stock Only Registered Direct Offering"
2020-06-22,ViralClear Partners with Catalent on Potential Treatment for COVID-19
2020-06-17,ViralClear Opens Enrollment with First Patient Dosing in Phase II Human Trial of Anti-Viral MMPD Oral Solution for Treatment of COVID-19
2020-06-08,"Reminder - BioSig Subsidiary, ViralClear to Host Conference Call on June 9th to Discuss Upcoming and Recent Developments for Phase II Human Clinical Trials of its Broad-Spectrum Oral Anti-Viral Candidate for Treatment of COVID-19"
2020-06-05,"ViralClear adds St. David's HealthCare in Austin, Texas, to its Planned Phase II trial for its Broad-Spectrum Oral Anti-Viral Candidate for COVID-19"
2020-06-04,BioSig Technologiess PURE EP System to be Presented in Heart Rhythm Society 2020 Science Sessions
2020-06-03,BioSig Technologies Expands Intellectual Property Portfolio
2020-06-01,ViralClear to Host Conference Call on June 9th to Discuss Upcoming and Recent Developments for Phase II Human Clinical Trials of its Broad-Spectrum Oral Anti-viral Candidate for Treatment of COVID-19
2020-05-28,"Michael R. Dougherty Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc."
2020-05-20,ViralClear Closes $10.8 Million Equity Financing for Development of COVID-19 Broad-Spectrum Oral Anti-Viral Candidate Merimepodib
2020-05-18,"FDA Clears the Investigational New Drug Application to Enable the Phase II Trial of ViralClears Merimepodib, Oral Solution to Treat Adult Patients with Advanced COVID-19, to Proceed"
2020-05-14,"ViralClear Publishes in F1000 Research In Vitro Data Demonstrating Synergy between Merimepodib and Remdesivir Against SARS-CoV-2, the Cause of COVID-19"
2020-05-07,"Michael Schmertzler Joins the Board of ViralClear Pharmaceuticals, a Majority-Owned Subsidiary of BioSig Technologies, Inc."
2020-05-05,"Biotech and Investment Veteran Dennis Purcell Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc."
2020-05-05,Could This Under-the-Radar Biotech Piggyback on Gilead's Remdesivir Success?
2020-05-01,BioSig Resumes Clinical Activities with PURE EP System
2020-04-30,ViralClear Submits In Vitro Data on Merimepodib and Remdesivir Synergistic Activity Against the COVID-19 Novel Coronavirus to a Peer-Reviewed Journal
2020-04-24,BioSig to Host Conference Call on Recent Developments of Subsidiary ViralClear and its Broad-Spectrum Oral Anti-Viral Candidate Merimepodib for the Treatment of COVID-19
2020-04-24,"BioSig Subsidiary ViralClear Submits Investigational New Drug Application to the FDA for Phase II Clinical Trials for Merimepodib, an Orally Administered Treatment for Patients with COVID-19"
2020-04-23,ViralClear Publishes Comparative In Vitro Data on Merimepodib and Remdesivir Activity Against the COVID-19 Novel Coronavirus in F1000 Research
2020-04-21,"Tony Zook Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc."
2020-04-21,BioSig Subsidiary ViralClear Submits Application for Vicromax Through FDAs Coronavirus Treatment Acceleration Program (CTAP) to Seek Acceleration of its Planned Clinical Trials
2020-04-17,BioSig Issues April 2020 Shareholder Update Letter
2020-04-17,New startup with local ties testing compound with Mayo Clinic to starve COVID-19
2020-04-16,Mayo Clinic preparing to Commence Phase II FDA clinical trial for the treatment of COVID-19 with Vicromax
2020-04-09,Positive Data Generated by Biosig Subsidiary ViralClear on Covid-19 Coronavirus Published in bioRxiv
2020-04-03,"BioSig to Host Telebriefing on Development Updates Regarding Vicromax(tm), a Novel Broad-Spectrum Anti-Viral Candidate That May Treat COVID-19"
2020-03-31,"Jerome Zeldis, M.D., Ph.D, Appointed as Executive Chair of ViralClear Pharmaceuticals, Inc."
2020-03-25,BioSig subsidiary NeuroClear acquires license for a broad-spectrum anti-viral agent that may treat COVID-19. Laboratory results demonstrate high level of activity against COVID-19 in cell culture
2020-03-22,"Who Has Been Buying BioSig Technologies, Inc. (NASDAQ:BSGM) Shares?"
2020-03-10,"Florida Cardiologist Zachariah P. Zachariah, M.D. Joins BioSig Technologies, Inc. Advisory Board"
2020-03-04,"BioSig Appoints John W. Osborn, Ph.D. as Consultant on Autonomic Neuromodulation"
2020-03-03,BioSig to Webcast its Presentation at the Cowen and Companys 40th Annual Health Care Conference
2020-02-26,BioSig to Present at the Cowen & Co. 40th Annual Health Care
2020-02-25,BioSig Announces Closing of Public Offering of Common Stock
2020-02-21,BioSig Announces $10 Million Public Offering of Common Stock
2020-02-21,"The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion"
2020-02-20,BioSig Announces Proposed Public Offering of Common Stock
2020-02-19,BioSig Completes 100th Patient Case with PURE EP(TM) System
2020-01-21,BioSig to Present at the 25th Annual International AF Symposium
2020-01-16,BioSig to Commence Patient Cases at Mayo Clinic
2020-01-14,BioSig Awarded Additional US Patent Claims for its PURE EP(TM) System
2019-12-23,"BioSig Technologies, Inc. (NASDAQ:BSGM): What Does Its Beta Value Mean For Your Portfolio?"
2019-12-03,BioSig Technologies Announces New Collaboration on Development of Artificial Intelligence Solutions in Healthcare
2019-12-02,BioSig Technologies Partners Mayo Clinic to Treat Arrhythmia
2019-11-26,BioSig Technologies Signs Three New Licensing Agreements with Mayo Clinic
2019-11-21,BioSig Commences Clinical Trial Enrollment for PURE EP System
2019-11-18,BioSig Technologies Welcomes the Creation of New Bioelectronic Medicine Alliance
2019-11-14,BioSig Technologies Issues November 2019 Shareholder Letter
2019-11-07,BioSig Technologies Invests in Union Colleges Internship Program
2019-11-06,"Sasha Gentling, CFA Joins BioSig as Director of Business Development"
2019-10-29,BioSig Appoints Andrew Ballou as Vice President of Investor Relations
2019-10-24,Here's Why We're Watching BioSig Technologies's (NASDAQ:BSGM) Cash Burn Situation
2019-10-15,"BioSig Opens a Technology Development Office in Rochester, MN"
2019-10-10,BioSig to Participate at The 14th Annual International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy
